Rutger K Balvers
Overview
Explore the profile of Rutger K Balvers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
166
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cakmak M, Mohammadian S, Keil V, Schouten J, de Witt Hamer P, van der Vaart T, et al.
Eur Radiol
. 2025 Feb;
PMID: 40016316
Objective: To examine whether MRI with routine gadolinium-based contrast agent (GBCA) administration in the long-term surveillance of adult-type diffuse glioma identifies tumour progression earlier than T2-weighted (T2w) and/or T2w fluid-attenuated...
2.
Stavrakaki E, Belcaid Z, Balvers R, Vogelezang L, van den Bossche W, Alderliesten D, et al.
Cancers (Basel)
. 2025 Feb;
17(4).
PMID: 40002198
: Access to high-quality patient-derived brain tumor tissues is instrumental for translational neuro-oncology research. Glioblastoma tumor material resected by ultrasonic aspiration (UA) during surgery offers an abundant source of material;...
3.
van Steenhoven R, Salih S, de Vries J, Smets I, Verdijk R, Gardeniers M, et al.
Ann Clin Transl Neurol
. 2025 Feb;
PMID: 39981762
Objective: A substantial part of central nervous system (CNS) disorders remains unexplained, despite various new and minimally invasive diagnostic techniques. Within this rapidly developing diagnostic field, the precise role of...
4.
Viozzi I, Hannink G, Ardon H, Balvers R, Bosscher L, van Geest S, et al.
J Neurooncol
. 2025 Feb;
PMID: 39913047
Purpose: This registry-based study aims to examine the variation in biopsy and resection indications for glioblastoma patients across Dutch hospitals and to identify patient- and hospital-related factors associated with the...
5.
Pruis I, van Doormaal P, Balvers R, van den Bent M, Harteveld A, de Jong L, et al.
EBioMedicine
. 2024 Mar;
102:105068.
PMID: 38518652
Background: The aim of this study was to provide quantitative evidence for the potential of PSMA-targeting radioligand therapy (RLT) as treatment approach for malignant brain tumours, and to explore whether...
6.
Pruis I, Verburg F, Balvers R, Harteveld A, Feelders R, Vernooij M, et al.
J Nucl Med
. 2024 Mar;
65(5):688-692.
PMID: 38514085
Small functional pituitary tumors can cause severely disabling symptoms and early death. The gold standard diagnostic approach includes laboratory tests and MRI, with or without inferior petrosal sinus sampling (IPSS)....
7.
Stavrakaki E, van den Bossche W, Vogelezang L, Teodosio C, Mustafa D, van Dongen J, et al.
Cell Rep Methods
. 2024 Mar;
4(3):100716.
PMID: 38430913
Oncolytic virus (OV) clinical trials have demonstrated remarkable efficacy in subsets of patients with glioblastoma (GBM). However, the lack of tools to predict this response hinders the advancement of a...
8.
van Lith S, Pruis I, Tolboom N, Snijders T, Henssen D, Laan M, et al.
J Nucl Med
. 2023 Aug;
64(10):1526-1531.
PMID: 37652540
Upregulation of prostate-specific membrane antigen (PSMA) in neovasculature has been described in glioblastoma multiforme (GBM), whereas vasculature in nonaffected brain shows hardly any expression of PSMA. It is unclear whether...
9.
Ntafoulis I, Kleijn A, Ju J, Jimenez-Cowell K, Fabro F, Klein M, et al.
Br J Cancer
. 2023 Aug;
129(8):1327-1338.
PMID: 37620410
Background: Patient-derived glioma stem-like cells (GSCs) have become the gold-standard in neuro-oncological research; however, it remains to be established whether loss of in situ microenvironment affects the clinically-predictive value of...
10.
van Steenhoven R, de Vries J, Bruijstens A, Paunovic M, Nagtzaam M, Franken S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Aug;
10(6).
PMID: 37582614
Background And Objectives: The clinical criteria for autoimmune encephalitis (AE) were proposed by Graus et al. in 2016. In this study, the AE criteria were validated in the real world,...